NVIDIA CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NVIDIA CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $215.94B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $130.50B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $60.92B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $26.97B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $26.91B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $16.68B | Feb 24, 2023 |
| FY2022 | Jan 26, 2020 | $10.92B | Mar 18, 2022 |
| FY2018 | Jan 28, 2018 | $2.91B | Feb 28, 2018 |
| FY2018 | Oct 29, 2017 | $2.64B | Feb 28, 2018 |
| FY2018 | Jul 30, 2017 | $2.23B | Feb 28, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jan 30, 2022 | $26.91B | Mar 18, 2022 |
| FY2022 | Jan 31, 2021 | $16.68B | Mar 18, 2022 |
| FY2020 | Jan 26, 2020 | $3.11B | Feb 20, 2020 |
| FY2020 | Oct 27, 2019 | $3.01B | Feb 20, 2020 |
| FY2020 | Jul 28, 2019 | $2.58B | Feb 20, 2020 |
| FY2020 | Apr 28, 2019 | $2.22B | Feb 20, 2020 |
| FY2020 | Jan 27, 2019 | $2.21B | Feb 20, 2020 |
| FY2020 | Oct 28, 2018 | $3.18B | Feb 20, 2020 |
| FY2020 | Jul 29, 2018 | $3.12B | Feb 20, 2020 |
| FY2020 | Apr 29, 2018 | $3.21B | Feb 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $153.46B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $97.86B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $44.30B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $15.36B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $17.48B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $10.40B | Feb 24, 2023 |
| FY2020 | Jan 26, 2020 | $2.02B | Feb 20, 2020 |
| FY2020 | Oct 27, 2019 | $1.92B | Feb 20, 2020 |
| FY2020 | Jul 28, 2019 | $1.54B | Feb 20, 2020 |
| FY2020 | Apr 28, 2019 | $1.30B | Feb 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $120.07B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $72.88B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $29.76B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $4.37B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $9.75B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $4.33B | Feb 24, 2023 |
| FY2020 | Jan 26, 2020 | $950.00M | Feb 20, 2020 |
| FY2020 | Oct 27, 2019 | $899.00M | Feb 20, 2020 |
| FY2020 | Jul 28, 2019 | $552.00M | Feb 20, 2020 |
| FY2020 | Apr 28, 2019 | $394.00M | Feb 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $130.39B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $81.45B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $32.97B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $4.22B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $10.04B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $4.53B | Feb 24, 2023 |
| FY2022 | Jan 26, 2020 | $2.85B | Mar 18, 2022 |
| FY2021 | Jan 27, 2019 | $3.80B | Feb 26, 2021 |
| FY2020 | Jan 28, 2018 | $3.21B | Feb 20, 2020 |
| FY2019 | Jan 29, 2017 | $1.93B | Feb 21, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $18.50B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $12.91B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $8.68B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $7.34B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $5.27B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $3.92B | Feb 24, 2023 |
| FY2022 | Jan 26, 2020 | $2.83B | Mar 18, 2022 |
| FY2021 | Jan 27, 2019 | $2.38B | Feb 26, 2021 |
| FY2020 | Jan 28, 2018 | $1.80B | Feb 20, 2020 |
| FY2019 | Jan 29, 2017 | $1.46B | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $4.58B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $3.49B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $2.65B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $2.44B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $2.17B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $1.94B | Feb 24, 2023 |
| FY2022 | Jan 26, 2020 | $1.09B | Mar 18, 2022 |
| FY2021 | Jan 27, 2019 | $991.00M | Feb 26, 2021 |
| FY2020 | Jan 28, 2018 | $815.00M | Feb 20, 2020 |
| FY2019 | Jan 29, 2017 | $663.00M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $102.72B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $64.09B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $28.09B | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | $5.64B | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | $9.11B | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | $5.82B | Feb 24, 2023 |
| FY2022 | Jan 26, 2020 | $4.76B | Mar 18, 2022 |
| FY2021 | Jan 27, 2019 | $3.74B | Feb 26, 2021 |
| FY2020 | Jan 28, 2018 | $3.50B | Feb 20, 2020 |
| FY2019 | Jan 29, 2017 | $1.67B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Jan 29, 2012 | $138.74M | Mar 13, 2012 |
| FY2011 | Jan 30, 2011 | $97.89M | Mar 13, 2012 |
| FY2011 | Jan 31, 2010 | $77.60M | Mar 13, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $206.80B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $111.60B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | $65.73B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | $41.18B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | $44.19B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | $28.79B | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | $17.32B | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | $13.29B | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | $11.24B | Feb 21, 2019 |
| FY2018 | Jan 29, 2017 | $9.84B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $49.51B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $32.27B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | $22.75B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | $19.08B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | $17.58B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | $11.90B | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | $5.11B | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | $3.95B | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | $3.77B | Feb 21, 2019 |
| FY2018 | Jan 29, 2017 | $4.05B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $157.29B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $79.33B | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | $42.98B | Feb 25, 2026 |
| FY2026 | Jan 29, 2023 | $22.10B | Feb 25, 2026 |
| FY2025 | Jan 30, 2022 | $26.61B | Feb 26, 2025 |
| FY2024 | Jan 31, 2021 | $16.89B | Feb 21, 2024 |
| FY2023 | Jan 26, 2020 | $12.20B | Feb 24, 2023 |
| FY2022 | Jan 27, 2019 | $9.34B | Mar 18, 2022 |
| FY2021 | Jan 28, 2018 | $7.47B | Feb 26, 2021 |
| FY2020 | Jan 29, 2017 | $5.76B | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $20.83B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $5.19B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | $4.43B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | $4.37B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | $4.35B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | $4.19B | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | $618.00M | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | $618.00M | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | $618.00M | Feb 21, 2019 |
| FY2018 | Jan 29, 2017 | $618.00M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $146.97B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $68.04B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | $29.82B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | $10.17B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | $16.24B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | $18.91B | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | $14.97B | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | $12.57B | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | $8.79B | Feb 21, 2019 |
| FY2018 | Jan 29, 2017 | $6.11B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $10.61B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $8.59B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | $7.28B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | $3.39B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | $1.99B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | $847.00M | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | $10.90B | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | $782.00M | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | $4.00B | Feb 21, 2019 |
| FY2019 | Jan 29, 2017 | $1.77B | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | $8.47B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | $8.46B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | $9.71B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | $10.95B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | $10.95B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | $6.96B | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | $1.99B | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | $1.99B | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | $1.99B | Feb 21, 2019 |
| FY2018 | Jan 29, 2017 | $1.98B | Feb 28, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | 4 | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | 2 | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | 1 | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | 0 | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | 3 | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | 1 | Feb 24, 2023 |
| FY2020 | Jan 26, 2020 | 1 | Feb 20, 2020 |
| FY2020 | Oct 27, 2019 | 1 | Feb 20, 2020 |
| FY2020 | Jul 28, 2019 | 0 | Feb 20, 2020 |
| FY2020 | Apr 28, 2019 | 0 | Feb 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | 4 | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | 2 | Feb 25, 2026 |
| FY2026 | Jan 28, 2024 | 1 | Feb 25, 2026 |
| FY2025 | Jan 29, 2023 | 0 | Feb 26, 2025 |
| FY2024 | Jan 30, 2022 | 3 | Feb 21, 2024 |
| FY2023 | Jan 31, 2021 | 1 | Feb 24, 2023 |
| FY2020 | Jan 26, 2020 | 1 | Feb 20, 2020 |
| FY2020 | Oct 27, 2019 | 1 | Feb 20, 2020 |
| FY2020 | Jul 28, 2019 | 0 | Feb 20, 2020 |
| FY2020 | Apr 28, 2019 | 0 | Feb 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 25, 2026 | 24.30B | Feb 25, 2026 |
| FY2026 | Jan 26, 2025 | 24.48B | Feb 25, 2026 |
| FY2025 | Jan 28, 2024 | 24.64B | Feb 26, 2025 |
| FY2024 | Jan 29, 2023 | 2.47B | Feb 21, 2024 |
| FY2023 | Jan 30, 2022 | 2.51B | Feb 24, 2023 |
| FY2022 | Jan 31, 2021 | 2.48B | Mar 18, 2022 |
| FY2021 | Jan 26, 2020 | 612.00M | Feb 26, 2021 |
| FY2020 | Jan 27, 2019 | 606.00M | Feb 20, 2020 |
| FY2019 | Jan 28, 2018 | 606.00M | Feb 21, 2019 |
| FY2018 | Jan 29, 2017 | 585.00M | Feb 28, 2018 |